Working Group Awards

The ESC Working Groups support high-quality research at ESC Congress by awarding the two best abstracts by young members (under 40 years old) in their respective topic of expertise.

The first author of each best abstract will receive a financial award of €500.

Congratulations to this year's recipients of the Working Groups Awards! Click on the abstract title to access the recording of the presentation on ESC365. 

ESC WG on Adult Congenital Heart Disease

• Inflammation and fibrosis analysis on a systemic and tissue level in adult patients with a systemic right ventricle - Valerie Spalart
• Assisted reproductive technology in women with adult congenital heart disease compared to controls: a large national registry study - Frida Wedlund

WG on Aorta & Peripheral Vascular Diseases

• Predictors of wound recurrence after wound healing in patients with chronic limb-threatening ischemia - Kazuho Ukai
• HDL-associated phosphatidylserine normalizes vessel wall metabolism and architecture in atherosclerosis - Aurora Bernal 

WG on Atherosclerosis and Vascular Biology

• TREM2 mcrophage mitigates atherosclerosis by suppressing FTH1/NCOA4-dependent ferroptosis - Qiongjun Zhu
• Epigenetic editing of chromatin readers rescues doxorubicin-induced endothelial senescence and vascular dysfunction - Shafeeq Ahmed Mohammed

WG on Cardiac Cellular Electrophysiology

• AAV-mediated gene therapy improves cardiac function in humanized PLN-R14del mice: a preclinical model of PLN-R14del induced cardiomyopathy - Karen Gaar-Humphreys
• Investigation of a novel SLC4A3 variant causing short QT Syndrome: functional and pharmacological evaluation in a knock-in zebrafish model - Ming Zhu

WG on Cardiovascular Pharmacotherapy

• Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3 - Yuki Obayashi
• Efficacy of sotagliflozin among older adults: a pooled analysis of SCORED and SOLOIST-WHF - Rahul Aggarwal

WG on Cardiovascular Regenerative and Reparative Medicine

• In situ nano-engineered DNA-CAR T therapy alleviates cardiac fibrosis post myocardial infarction - Wutian Rao
• Targeting miR-148a-3p to reverse endothelial senescence and improve vascular repair post-MI - Laura Hehl

WG on Cardiovascular Surgery

• Clinical outcomes of patients undergoing percutaneous coronary intervention and transcatheter aortic valve implantation versus coronary artery bypass grafting and surgical aortic valve replacement - Nikolaos Ktenopoulos
• Long-term mortality in patients who survive 90 days after surgery for infective endocarditis versus the background population: a nationwide study - Sikander Tajik

WG on Cellular Biology of the Heart

• The BET protein inhibitor Apabetalone rescues cardiometabolic heart failure with preserved ejection fraction by suppressing myocardial and systemic inflammation: a study in mice and humans - Era Gorica
• Metabolic reprogramming-mediated CREB1 lactylation exacerbates valvular interstitial cell osteogenesis in calcific aortic valve disease - Fei Xu

WG on Coronary Pathophysiology and Microcirculation

• The diagnostic performance of EST in identifying CMD in patients with ANOCA: insights into endotypes and clinical implications - Ali Aldujeli
• Sex disparities in ischaemic heart disease mortality in South Asia: a global burden of disease 2021 analysis - Tania Rahaman

WG on Development Anatomy and Pathology

• Lysine methyltransferase Set7 drives obesity-induced endothelial dysfunction by impairing mRNA splicing expression and eNOS function - Julia Sanchez Ceinos
• Tricuspid valve morphology assessment in adults with a systemic right ventricle with transthoracic three-dimensional echocardiography - Flavia Fusco

WG on e-Cardiology

• A digital twin approach for automated left ventricular wall thickness assessment from 2D echocardiography - Joao Filipe Fernandes
• Identification of at-risk populations for cardiac amyloidosis: a multimodal machine learning development and validation study - Christian Nitsche

WG on Myocardial & Pericardial Diseases

• Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM - Albree Tower-Rader
• Gain-of-function vs. loss-of-function effects of DES variants on cardiodesminopathy phenotypes - Mario Urtis

WG on Myocardial Function

• Neutrophil-driven inflammation in takotsubo syndrome: insights from patient data and a translational murine model - Katharina Kurz
• Alveolar macrophages promote inflammation within the lung micro-environment and drive endothelial damage in obese HFpEF-related pulmonary hypertension - Valeria Masciovecchio

WG on Pulmonary Circulation & Right Ventricular Function

• Efficacy and safety of prolonged rivaroxaban treatment for high-bleeding risk cancer patients with acute low-risk pulmonary embolism: a post-hoc subgroup analysis of the ONCO PE trial - Tomoyuki Nagai
• Targeting alpha 5 beta 1 integrin as a therapeutic strategy to combat right ventricular dysfunction in pulmonary arterial hypertension - Sarah-Eve Lemay

WG on Thrombosis

• ZBP1 exacerbates myocardial ischemia-reperfusion injury through the induction of non-canonical cardiomyocyte PANoptosis - Xiaokai Zhang
• Is the risk of ischemic stroke lower in atrial flutter compared to atrial fibrillation? - Hermon Eyob Fesseha

Presentations are available on demand and all year long on ESC 365 - The cardiology knowledge hub. Become an ESC Professional Member and access a wide range of benefits.

Join us